RS53999B1 - Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor - Google Patents

Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Info

Publication number
RS53999B1
RS53999B1 RS20150319A RSP20150319A RS53999B1 RS 53999 B1 RS53999 B1 RS 53999B1 RS 20150319 A RS20150319 A RS 20150319A RS P20150319 A RSP20150319 A RS P20150319A RS 53999 B1 RS53999 B1 RS 53999B1
Authority
RS
Serbia
Prior art keywords
letters
thickness
front panel
sides
numbers
Prior art date
Application number
RS20150319A
Other languages
English (en)
Serbian (sr)
Inventor
Sreenivasa Reddy Mundla
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of RS53999B1 publication Critical patent/RS53999B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RS20150319A 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor RS53999B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70164105P 2005-07-22 2005-07-22
PCT/US2006/025377 WO2007018818A1 (en) 2005-07-22 2006-06-29 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor

Publications (1)

Publication Number Publication Date
RS53999B1 true RS53999B1 (sr) 2015-10-30

Family

ID=37450942

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150319A RS53999B1 (sr) 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Country Status (16)

Country Link
US (1) US7872020B2 (https=)
EP (1) EP1910370B1 (https=)
JP (1) JP5242391B2 (https=)
BR (1) BRPI0613639A2 (https=)
CA (1) CA2616196C (https=)
DK (1) DK1910370T3 (https=)
ES (1) ES2542425T3 (https=)
HR (1) HRP20150474T1 (https=)
HU (1) HUE025209T2 (https=)
IL (1) IL188181A (https=)
MX (1) MX2008001020A (https=)
PL (1) PL1910370T3 (https=)
PT (1) PT1910370E (https=)
RS (1) RS53999B1 (https=)
SI (1) SI1910370T1 (https=)
WO (1) WO2007018818A1 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081810A1 (es) 2010-04-07 2012-10-24 Bayer Cropscience Ag Piridinilpirazoles biciclicos
DK2731949T3 (en) * 2011-07-13 2018-06-14 Tiumbio Co Ltd 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS
WO2014072517A1 (en) 2012-11-12 2014-05-15 Institució Catalana De Recerca I Estudis Avançats Methods and kits for the prognosis of colorectal cancer
LT2970890T (lt) 2013-03-14 2020-07-10 The Brigham And Women`S Hospital, Inc. Kompozicijos ir būdai, skirti epitelinių kamieninių ląstelių padauginimui ir kultivavimui
WO2016037016A1 (en) 2014-09-03 2016-03-10 The Brigham And Women's Hospital, Inc. Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
HK1247861A1 (zh) 2015-01-30 2018-10-05 President And Fellows Of Harvard College 用於癌症治疗的肿瘤周围和肿瘤内部材料
ES2918924T3 (es) 2015-04-01 2022-07-21 Rigel Pharmaceuticals Inc Inhibidores de TGF-beta
US10669528B2 (en) 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
KR102738306B1 (ko) 2015-12-15 2024-12-03 브리스톨-마이어스 스큅 컴퍼니 Cxcr4 수용체 길항제
CN108779437A (zh) 2016-01-08 2018-11-09 麻省理工学院 分化的肠内分泌细胞和胰岛素产生细胞的制备
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
WO2017161001A1 (en) 2016-03-15 2017-09-21 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
CN109548403A (zh) 2016-07-07 2019-03-29 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
EP3527570A4 (en) 2016-10-14 2020-04-15 Jiangsu Hengrui Medicine Co., Ltd. FIVE-LINKED HETERARYARYLE CYCLE BRIDGE DERIVATIVE, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF
US11066419B2 (en) 2016-12-30 2021-07-20 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using same
CN110582497B (zh) * 2017-03-17 2022-03-11 杭州领业医药科技有限公司 Galunisertib的晶型及其制备方法和药物组合物
US10995083B2 (en) 2017-03-21 2021-05-04 Hangzhou Solipharma Co., Ltd. Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
WO2019042383A1 (zh) * 2017-08-31 2019-03-07 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019105082A1 (zh) * 2017-11-30 2019-06-06 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019137027A1 (zh) * 2018-01-12 2019-07-18 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
JP2021518413A (ja) 2018-03-20 2021-08-02 アイカーン スクール オブ メディシン アット マウント サイナイ キナーゼ阻害剤化合物及び組成物ならびに使用方法
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
CN113195707A (zh) 2018-08-17 2021-07-30 频率治疗公司 用于通过上调jag-1来生成毛细胞的组合物和方法
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
WO2020142485A1 (en) 2018-12-31 2020-07-09 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
CN115282280A (zh) * 2022-08-12 2022-11-04 中国科学技术大学 TGF-β1信号抑制剂的新用途
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
GB202309553D0 (en) 2023-06-24 2023-08-09 Ucl Business Ltd Compostions and uses thereof
IL326136A (en) 2023-08-07 2026-03-01 Revolution Medicines Inc RMC-6291 for use in the treatment of a disease or disorder associated with the RAS protein
US20250154171A1 (en) 2023-10-12 2025-05-15 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
US20250375445A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1397364B1 (en) * 2001-05-24 2007-07-25 Eli Lilly And Company Novel pyrrole derivatives as pharmaceutical agents
CA2506799A1 (en) 2002-11-21 2004-06-10 Eli Lilly And Company Mixed lineage kinase modulators
UA80571C2 (en) * 2002-11-22 2007-10-10 Lilly Co Eli Quinolinyl-pyrrolopyrazoles

Also Published As

Publication number Publication date
US20100120854A1 (en) 2010-05-13
JP5242391B2 (ja) 2013-07-24
CA2616196A1 (en) 2007-02-15
PL1910370T3 (pl) 2015-09-30
US7872020B2 (en) 2011-01-18
DK1910370T3 (en) 2015-06-08
WO2007018818A1 (en) 2007-02-15
EP1910370A1 (en) 2008-04-16
BRPI0613639A2 (pt) 2012-02-22
PT1910370E (pt) 2015-06-30
JP2009502780A (ja) 2009-01-29
ES2542425T3 (es) 2015-08-05
MX2008001020A (es) 2008-03-25
IL188181A (en) 2014-05-28
HRP20150474T1 (xx) 2015-06-05
EP1910370B1 (en) 2015-04-22
SI1910370T1 (sl) 2015-06-30
CA2616196C (en) 2012-08-21
HUE025209T2 (en) 2016-03-29
IL188181A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
RS53999B1 (sr) Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor
US5760367A (en) Apparatus and method of engraving indicia on gemstones, and gemstones, produced thereby
CN105814623B (zh) 表面上的发光图案
US5419940A (en) Colorized acrylic award assembly and method of making
CN104148898A (zh) 具有微棱镜阵列结构的反光材料模具的制作方法
CN102275448A (zh) 高精细透光图案塑料面板的制作方法
US20060235564A1 (en) Method and multifunctional system for producing laser-induced images on the surfaces of various materials and inside transparent materials
DE112015000587T5 (de) System und Verfahren zum Laserschneiden von Saphir unter Verwendung mehrerer Gasmedien
CN110744205A (zh) 一种钛基多层复合材料激光深度标记方法
Dumont et al. Laser writing of 2D data matrices in glass
US5599594A (en) Simulated objects
CN203730486U (zh) 一种双面胶定位粘贴工装
GB2445129A (en) Screen printing apparatus and screen printing method
CN204936375U (zh) 一种贵金属磨砂镜面仿印薄片
MX2014011914A (es) Herramientas para elaborar articulos retrorreflectivos.
CN1280449C (zh) 制作硬质合金冲压模具的方法
CN114851762A (zh) 一种具备立体效果的彩色光伏组件及其制备方法
YU49429B (sh) Postupak za izradu informacione ploče sa natpisom radnje ili firme koji treba da simulira trodimenzionalnost slova, brojeva i drugih znakova
KR20060017074A (ko) 레이저가공 장식품 및 그 제조방법
CN214775131U (zh) 一种树脂光栅板
CN117577710B (zh) 一种增加彩色前板与光伏组件牢度的制作方法
WO2009016750A1 (ja) 服飾用物品、および服飾用物品の表示部の製造方法
CN209674620U (zh) 广告平面设计的教学辅助装置
CN207608768U (zh) 一种环保定位转移纸
CN207468983U (zh) 一种防伪环保转移纸